Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
KC Crew’s fall leagues set to be first players in overhauled Hy-Vee Arena
The newly renovated Hy-Vee Arena in Kansas City’s West Bottoms is like a giant sports coworking space, said Luke Wade. Coffee shops, restaurants, chiropractors, physical therapists, and other offerings are joining his adult sports and events company in the revamped former Kemper Arena facility, said Wade, founder of KC Crew. And although the arena officially…
KCMO provides welcoming spot for NY-based high-tech kennel startup, DogSpot
Kansas City stands out among 30 different DogSpot partner cities for cutting through bureaucracy to help startups grow, said Chelsea Brownridge. DogSpot — a service that delivers internet-connected, air-conditioned, standalone dog kennels for pet owners to “park” their dogs while, for example, shopping or running errands — teamed with the City of Kansas City, Missouri,…
Three fathers bring Whizz Bang potty-training game to market through Make48, Handy Camel
The Whizz Bang gamifies potty training and saves the bathroom floors of all parents, said Amy Gray. The device, which hooks on the underside of a toilet seat lid, emits a LED light target at the bottom the bowl. Once hit, the device plays musical praise, said Gray, the head of sales for Handy Camel,…
Reconciliation Services hopes to heal trauma in the heart of stigmatized Troost corridor
Commanded by Scripture, David Altschul journeyed into parts unknown, said his successor, Father Justin Mathews. In the mid-1980s, a philanthropic pull tugged at the heart of Altschul — a white, insurance salesman from Johnson County — and eventually led him into the distressed, history-rich neighborhoods that lined Troost Avenue on the east side of…